What is PureTech Health PLC (PRTC) stock price today?

PureTech Health PLC (PRTC) currently trades at $17.40 per share. The stock has a market capitalization of $441.56M and a P/E ratio of 10.67x.

Is PRTC stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, PureTech Health PLC has a Smart Value Score of 51/100 (Grade C), resulting in a "Hold" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is the PRTC stock price target for 2026?

WallStSmart's 12-month price target for PureTech Health PLC is $19.23.

What is PureTech Health PLC's revenue and earnings?

PureTech Health PLC has trailing twelve-month (TTM) revenue of $6.39M with profit margins of 793.00%. Earnings per share (EPS) is $1.70.

PRTC

PureTech Health PLC

NASDAQ: PRTC · HEALTHCARE · BIOTECHNOLOGY

$17.40

-4.08% today

Updated 2026-04-29

Market cap

$441.56M

P/E ratio

10.67

P/S ratio

69.09x

EPS (TTM)

$1.70

Dividend yield

—

52W range

$15 – $20

Volume

0.0M

Market cap

$441.56M

P/E ratio

10.67

P/S ratio

69.09x

EPS (TTM)

$1.70

Dividend yield

—

52W range

$15 – $20

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: C

Hold

Investment rating

7.3

Growth

B+

5.0

Quality

C+

5.0

Profitability

C+

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$46.00

+164.37%

12-Month target

$19.23

+10.52%

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Profit margin 793.00% — above average

+ Revenue growth 543.00% QoQ

Risks

- Negative free cash flow $-46.34M

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$9.98M	$2.09M	$3.33M	$4.83M	$6.39M
Net income	$-60.56M	$-50.35M	$-65.70M	$53.51M	$-44.60M
EPS	—	—	—	—	$1.70
Free cash flow	$-163.94M	$-180.97M	$-106.16M	$-134.38M	$-46.34M
Profit margin	-606.85%	-2,409.33%	-1,972.88%	1,108.33%	793.00%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PRTC	$441.56M	51	7.3	5.0	6.7	5.0	—	Buy
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

PureTech Health PLC trades at $17.40. representing a P/E of 10.67x trailing earnings. Our Smart Value Score of 51/100 indicates the stock is fair. TTM revenue stands at $6.39M. with profit margins at 793.00%.

Frequently asked questions

What is PureTech Health PLC's stock price?

PureTech Health PLC (PRTC) trades at $17.40.

Is PureTech Health PLC overvalued?

Smart Value Score 51/100 (Grade C, Hold).

What is the price target of PureTech Health PLC (PRTC)?

The analyst target price is $46.00, representing +164.4% upside from the current price of $17.40.

What is PureTech Health PLC's revenue?

TTM revenue is $6.39M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio69.09x

ROE9.44%

Beta0.71

50D MA$16.85

200D MA$17.37

Shares out0.02B

Float0.17B

Short ratio—

Avg volume0.0M

Performance

1 week+1.62%

1 month+25.10%

3 months-2.84%

YTD+9.01%

1 year—

3 years—

5 years—

Compare

PRTC vs LLY →PRTC vs JNJ →PRTC vs ABBV →Stock screener →